Maravai LifeSciences Holdings Inc - Class A

Research Maravai LifeSciences Holdings Inc - Class A (MRVI) on Bullrun: market cap USD 942.56M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerMRVI
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 942.56M
• Financial periodFY2025
• RevenueUSD 185.74M
• Revenue growth-28.3%
• Net income-USD 130.80M
• Free cash flow-USD 70.72M
• Gross margin18.3%

Valuation Snapshot

latest market cap is USD 942.56M.

About Maravai LifeSciences Holdings Inc - Class A

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operates through two segments: TRILINK and CYGNUS.

Frequently asked questions

What is Maravai LifeSciences Holdings Inc - Class A's market cap?

Maravai LifeSciences Holdings Inc - Class A's market capitalization is USD 942.56M.

What does Maravai LifeSciences Holdings Inc - Class A do?

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.